Bailing Pharma Gets Clinical Trial Approval for Diabetic Retinopathy Traditional Chinese Tablets; Shares Rise 5%
Bailing Pharma Gets Clinical Trial Approval for Diabetic Retinopathy Traditional Chinese Tablets; Shares Rise 5%
百靈藥業獲得糖尿病視網膜病變傳統中藥片臨床試驗批准；股價上漲5%
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間